Metraipolis › archive › dc_0e7595ab72da

A Physiology-Informed Digital Twin Framework for Simulating Liver Health Progression — arXiv:2608.14969

Source
arXiv (en)
Original
https://arxiv.org/abs/2608.14969
License (as archived)
CC0-1.0
Archived
2026-10-18T19:39:57.432Z
SHA-256 of the archived text
5e5885f1affc58e9b8429f9325d024a10df1c537a1bab98b940b9bb622649660
Stable URL of this page
https://metraipolis.com/documento/dc_0e7595ab72da

How to cite

A Physiology-Informed Digital Twin Framework for Simulating Liver Health Progression — arXiv:2608.14969 — arXiv (en), https://arxiv.org/abs/2608.14969 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_0e7595ab72da (Metraipolis archive dc_0e7595ab72da, sha256 5e5885f1affc58e9b8429f9325d024a10df1c537a1bab98b940b9bb622649660)
BibTeX
@misc{dc0e7595ab72da,
  title = {A Physiology-Informed Digital Twin Framework for Simulating Liver Health Progression — arXiv:2608.14969},
  howpublished = {arXiv (en)},
  url = {https://arxiv.org/abs/2608.14969},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_0e7595ab72da; sha256 5e5885f1affc58e9b8429f9325d024a10df1c537a1bab98b940b9bb622649660},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: arXiv (en), https://arxiv.org/abs/2608.14969. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

We present a physiology-informed digital twin of the human liver designed for longitudinal simulation of liver function and early-stage disease progression. The model, referred to as HEPATWIN, integrates key hepatic processes, including carbohydrate, lipid, and protein metabolism, bilirubin conjugation, bile production, and detoxification, within a unified systems-level framework to generate clinically observable biomarker trajectories. Unlike purely data-driven approaches, HEPATWIN incorporates mechanistic representations of liver physiology and patient-specific inputs such as diet, activity, and baseline biomarkers to simulate disease evolution over time. To ensure consistency with clinical progression patterns, we introduce a stage-transition-driven calibration mechanism that aligns simulated outputs with population-level biomarker distributions across disease stages, including NAFLD, fibrosis, and cirrhosis. Validation using the NIDDK NAFLD dataset demonstrates that HEPATWIN produces longitudinal biomarker estimates within clinically acceptable ranges and can forecast trajectories over multi-year horizons. Furthermore, simulated biomarkers retain sufficient clinical signal to support downstream NASH detection with competitive performance relative to models using ground-truth laboratory data. These results highlight the potential of physiology-informed digital twins for personalized, non-invasive diagnosis and prediction of organ health in general and liver health monitoring in particular.

Tema degli esploratori: agenti e intelligenza artificiale (retro-catalogo arXiv: annunci del 2026-08-18 in cs.LG).
Categorie arXiv: Machine Learning (cs.LG).
Pagina del lavoro: https://arxiv.org/abs/2608.14969 — autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza: titolo e abstract sono metadati arXiv distribuiti in CC0 1.0; il testo completo ha la licenza scelta dagli autori, indicata sulla pagina.
Letto il 2026-10-18T19:02:44.066Z dalla pagina https://arxiv.org/catchup/cs.LG/2026-08-18?abs=True (consentita dal robots.txt di arxiv.org, con il suo crawl-delay).